Skip to main content

Table 4 System suitability parameters for XIP and VAL in both pure and plasma samples

From: Quality by design approach for development and validation of a RP-HPLC method for simultaneous estimation of xipamide and valsartan in human plasma

Parameters

Pure sample

Plasma sample

Reference values [39]

XIP

VAL

XIP

VAL

 

Retention time, tR

3.35 ± SD

4.66 ± SD

3.23 ± SD

4.34 ± SD

 

Capacity factor, k'

1.58

2.59

1.49

2.26

Accepted kʹ value (1–10)

Peak asymmetry (Tailing factor, T)

1.00

0.92

1.18

1.15

Accepted T value ≤ 2

Theoretical plates, N

3620

3587

3384

3554

Accepted N value > 2000

Resolution, Rs

4.91

4.59

Accepted value > 2

Selectivity (separation factor, α)

1.64

1.52

Â